M&A Deal Summary

Nipro Acquires Infraredx

On September 11, 2015, Nipro acquired medical products company Infraredx

Acquisition Highlights
  • This is Nipro’s 2nd transaction in the Medical Products sector.
  • This is Nipro’s 2nd transaction in the United States.
  • This is Nipro’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2015-09-11
Target Infraredx
Sector Medical Products
Buyer(s) Nipro
Deal Type Add-on Acquisition

Target

Infraredx

Burlington, Massachusetts, United States
website
Infraredx, Inc. is an intravascular medical device company committed to advancing the diagnosis and management of coronary artery disease globally.

Search 177,612 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Nipro

Osaka, Japan

website


Category Company
Founded 1947
Sector Medical Products
Employees35,251
Revenue 494.8B JPY (2022)
DESCRIPTION

Nipro is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-related products. Nipro was founded in 1947 and is based in Osaka, Japan.


DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 2 of 2
Year (2015) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-15 Home Diagnostics

Fort Lauderdale, Florida, United States

Home Diagnostics is a developer, manufacturer and marketer of diabetes management products. Home Diagnostics offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics product line includes TRUE2go™, TRUEresult^®, TRUEtrack^®, TRUEbalance™, Sidekick^®, TRUEread^® and Prestige IQ^® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-07 Trividia Health

Fort Lauderdale, Florida, United States

Trividia Health, Inc. is a manufacturer and marketer of blood glucose monitoring products and diabetes management supplies that are available in national chains and through mail order pharmacies.

Sell $273M